Ovarian function in the rat following irreversible inhibition of L-ornithine decarboxylase.
D012437:Adenosylmethionine Decarboxylase / Q000037:antagonists & inhibitors; D000818:Animals; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D000518:Eflornithine; D004971:Estrus; D005260:Female; D008935:Mitoguazone / Q000031:analogs & derivatives / Q000494:pharmacology; D009952:Ornithine / Q000031:analogs & derivatives / Q000494:pharmacology; D065108:Ornithine Decarboxylase Inhibitors; D010053:Ovary / Q000201:enzymology*; D010060:Ovulation / Q000187:drug effects*; D011247:Pregnancy; D011700:Putrescine / Q000378:metabolism; D051381:Rats; D013095:Spermidine / Q000378:metabolism; D013096:Spermine / Q000378:metabolism
D065108:Ornithine Decarboxylase Inhibitors; D013096:Spermine; C012430:1,1'-(methylethanediylidenedinitrilo)bis(3-aminoguanidine); D009952:Ornithine; D002262:Carboxy-Lyases; D012437:Adenosylmethionine Decarboxylase; D008935:Mitoguazone; D013095:Spermidine; D011700:Putrescine; D000518:Eflornithine